Vasopressor resident survival guide
Sepsis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Vasopressor resident survival guide On the Web |
American Roentgen Ray Society Images of Vasopressor resident survival guide |
Risk calculators and risk factors for Vasopressor resident survival guide |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2]
Definition
Causes
Life Threatening Causes
Common Causes
Prognosis
Management
Vasopressors | |||||||||||||||||||||||||||||||||||||||||||||||||
Norepinephrine | Dopamine | Vasopressin | Phenylephrine | Dobutamine | |||||||||||||||||||||||||||||||||||||||||||||
Mechanism of action | *Mainly α1 (Vasoconstrictive) *β1 (↑contractility) | *Mainly β1(↑contractility) *α1(Vasoconstrictive) | *V1 receptor of GIT vasculatures *Antidiuretic effects | *Pure α1 (Vasoconstrictive) *No β1 | *Mainly β1 (↑contractility) *β2 arterial smooth muscle (Hypotensive) | ||||||||||||||||||||||||||||||||||||||||||||
Indication | {{{ D02 }}} | {{{ D03 }}} | {{{ D04 }}} | {{{ D05 }}} | {{{ D06 }}} | ||||||||||||||||||||||||||||||||||||||||||||
Dose | {{{ E02 }}} | {{{ E03 }}} | {{{ E04 }}} | {{{ E05 }}} | {{{ E06 }}} | ||||||||||||||||||||||||||||||||||||||||||||
Complications | {{{ F02 }}} | {{{ F03 }}} | {{{ F04 }}} | {{{ F05 }}} | {{{ F06 }}} | ||||||||||||||||||||||||||||||||||||||||||||
Cautions | {{{ G02 }}} | {{{ G03 }}} | {{{ G04 }}} | {{{ G05 }}} | {{{ G06 }}} | ||||||||||||||||||||||||||||||||||||||||||||
Do's
- Assess the cause of shock
- Always volume fluid resuscitation first
- Norepinephrine in undifferentiated shock.